[Passive immunotherapy with monoclonal antibodies].
Bokemeyer
Carsten
C
Medizinische Klinik III (Onkologie/Hämatologie mit den Sektionen KMT und Pneumologie), Universitätsklinikum Eppendorf, Hamburg, Germany.
Panse
Jens
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000920:Antibody-Dependent Cell Cytotoxicity / Q000187:drug effects / Q000276:immunology; D002470:Cell Survival / Q000276:immunology; D003167:Complement Activation / Q000187:drug effects / Q000276:immunology; D019337:Hematologic Neoplasms / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007110:Immunity, Active / Q000187:drug effects / Q000276:immunology; D007116:Immunization, Passive; D016393:Lymphoma, B-Cell / Q000276:immunology / Q000628:therapy; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
D000911:Antibodies, Monoclonal